Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010

British Journal of Ophthalmology

Volumn 98, Issue 5, 2014, Pages 629-638

  Bourne, Rupert R A ^a   Jonas, Jost B ^b   Flaxman, Seth R ^c   Keeffe, Jill ^d,e   Leasher, Janet ^f   Naidoo, Kovin ^g,h   Parodi, Maurizio B ⁱ   Pesudovs, Konrad ^j   Price, Holly ^a   White, Richard A ^k   Wong, Tien Y ^l   Resnikoff, Serge ^h   Taylor, Hugh R ^m  

^a ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^b MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^c Carnegie Mellon University   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e L V PRASAD EYE INSTITUTE   (India)

^f NOVA SOUTHEASTERN UNIVERSITY   (United States)

^g UNIVERSITY OF KWAZULU NATAL   (South Africa)

^h BRIEN HOLDEN VISION INSTITUTE   (Australia)

ⁱ VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^j FLINDERS UNIVERSITY   (Australia)

^k NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^l SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^m UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPIDEMIOLOGY; GLAUCOMA; PUBLIC HEALTH;

BLINDNESS; DEVELOPED COUNTRIES; EUROPE, EASTERN; EUROPEAN CONTINENTAL ANCESTRY GROUP; EYE DISEASES; HUMANS; PREVALENCE;

EID: 84898817545     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-304033     Document Type: Article

References (26)

1. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-223.
2. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96.
3. Stevens G, White R, Flaxman SR, et al. Global prevalence of visual impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology 2013;120:2377-84.
4. Bourne R, Price H, Taylor H, et al. New systematic review methodology for visual impairment and blindness for the 2010 Global Burden of Disease study. Ophthalmic Epidemiol 2013;20:33-9.
5. http://www.anglia.ac.uk/ruskin/en/home/microsites/veru/ other-research-areas/global-burden-of-diseases.Maincontent.0006.file.tmp/ Global%20Burden%20of%20Diseases%20Vision%20Loss%20Group%20-%20Web%20Appendix. pdf (accessed 3 Jul 2013)
6. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:357-64.
7. Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998;116:653-8.
8. Weih LM, VanNewkirk MR, McCarty CA, et al. Age-specific causes of bilateral visual impairment. Arch Ophthalmol 2000;118:264-9.
9. Wang JJ, Foran S, Mitchell P. Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 2000;28:268-73.
10. Dineen BP, Bourne RR, Ali SM, et al. Prevalence and causes of blindness and visual impairment in Bangladeshi adults: results of the National Blindness and Low Vision Survey of Bangladesh. Br J Ophthalmol 2003;87:820-8.
11. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477-85.
12. Saw SM, Foster PJ, Gazzard G, et al. Causes of blindness, low vision, and questionnaire-assessed poor visual function in Singaporean Chinese adults: the Tanjong Pagar Survey. Ophthalmology 2004;111:1161-8.
13. Hsu WM, Cheng CY, Liu JH, et al. Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 2004;111:62-9.
14. Jadoon MZ, Dineen B, Bourne RR, et al. Prevalence of blindness and visual impairment in Pakistan: the Pakistan National Blindness and Visual Impairment Survey. Invest Ophthalmol Vis Sci 2006;47:4749-55.
15. Abou-Gareeb I, Lewallen S, Bassett K, et al. Gender and blindness: a meta-analysis of population-based prevalence surveys. Ophthalmic Epidemiol 2001;8:39-56.
16. Kawasaki R, Yasuda M, Song SJ, et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 2010;117:921-7.
17. Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet 2012;379:1739-48.
18. Pan CW, Zheng YF, Anuar AR, et al. Prevalence of refractive errors in a multiethnic Asian population: the Singapore epidemiology of eye disease study. Invest Ophthalmol Vis Sci 2013;54:2590-8.
19. Lim LS, Mitchell P, Seddon JM, et al. Age-related macular degeneration. Lancet 2012;379:1728-38.
20. Cheung N, Wong TY. Changing trends of blindness: the initial harvest from translational public health and clinical research in ophthalmology. Am J Ophthalmol 2012;153:193-5.
21. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;10;124-36.
22. Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-64.
23. Chiang PP, Lamoureux EL, Zheng Y, et al. Frequency and risk factors of non-retinopathy ocular conditions in people with diabetes: the Singapore Malay Eye Study. Diabet Med 2013;30:e32-40.
24. Xu L, Wang Y, Li Y, et al. Causes of blindness and visual impairment in an urban and rural area in Beijing: the Beijing Eye Study. Ophthalmology 2006;113:1134.e1-11.
25. Wolfs RC, Borger PH, Ramrattan RS, et al. Changing views on open-angle glaucoma: definitions and prevalences-The Rotterdam Study. Invest Ophthalmol Vis Sci 2000;41:3309-21.
26. World Health Organization. Coding instructions for the WHO/PBL eye examination record (version III). PBL/88.1. http://www.who.int/ncd/vision2020- actionplan/documents/pbl-88-1.pdf. (accessed 14 May 2013).